The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
126375211 12637521 1 I 20160728 20160809 20160809 EXP IT-TEVA-683265ISR TEVA MARCHEI E, PALMI I, PICHINI S, PACIFICI R, ANTON IRA, COSTA ORVAY JA ET AL. SEGMENTAL HAIR TESTING TO DISCLOSE CHRONIC EXPOSURE TO PSYCHOACTIVE DRUGS.ADICCIONES. 2016; 28(3):158-162 4.00 YR M Y 0.00000 20160809 MD IT IT

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
126375211 12637521 1 PS SERTRALINE SERTRALINE HYDROCHLORIDE 1 Oral U 76465
126375211 12637521 2 SS QUETIAPINE. QUETIAPINE 1 Oral U 77745

Indications of drugs used

no results found

Outcome of event

Event ID CASEID OUTC COD
126375211 12637521 HO
126375211 12637521 OT
126375211 12637521 LT

Reactions reported

Event ID CASEID DRUG REC ACT PT
126375211 12637521 Asthenia
126375211 12637521 Blepharospasm
126375211 12637521 Constipation
126375211 12637521 Drug administration error
126375211 12637521 Dysarthria
126375211 12637521 Dystonia
126375211 12637521 Gait disturbance
126375211 12637521 Lacrimation increased
126375211 12637521 Miosis
126375211 12637521 Mydriasis
126375211 12637521 Prescription drug used without a prescription
126375211 12637521 Rash erythematous
126375211 12637521 Somnolence
126375211 12637521 Tonic convulsion
126375211 12637521 Toxicity to various agents
126375211 12637521 Urinary incontinence

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

no results found